Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatment-Reference-Cited by-同舟云学术

Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatment

Published:2017-06-09 Issue:10 Volume:76 Page:1747-1750
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Belkhir Rakiba,Burel Sébastien Le,Dunogeant Laetitia,Marabelle Aurélien,Hollebecque Antoine,Besse Benjamin,Leary Alexandra,Voisin Anne-Laure,Pontoizeau Clémence,Coutte Laetitia,Pertuiset Edouard,Mouterde Gaël,Fain Olivier,Lambotte Olivier,Mariette Xavier

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Cited by 209 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tocilizumab provides dual benefits in treating immune checkpoint inhibitor-associated arthritis and preventing relapse during ICI rechallenge: the TAPIR study;Annals of Oncology;2024-09

2. Toxicity in the era of immune checkpoint inhibitor therapy;Frontiers in Immunology;2024-08-23

3. Tocilizumab provides dual benefits in treating immune checkpoint inhibitor-associated arthritis and preventing relapse during ICI rechallenge: the TAPIR study;2024-07-12

4. Polymyalgia rheumatica and giant cell arteritis induced by immune checkpoint inhibitors: A systematic literature review highlighting differences from the idiopathic forms;Autoimmunity Reviews;2024-07

5. Sicca syndrome/Sjögren’s disease associated with cancer immunotherapy: a narrative review on clinical presentation, biomarkers, and management;Expert Review of Clinical Immunology;2024-06-25